Board MeetingMay 5, 2026, 04:03 PM
Acumen Pharmaceuticals to Report Q1 Results on May 12
AI Summary
Acumen Pharmaceuticals, Inc. announced it will report its first-quarter financial results on Tuesday, May 12, 2026. Following the release, the company will host a conference call and live audio webcast at 8:00 a.m. ET to provide a business and financial update. Interested parties are required to register in advance for the call, and an archived webcast will be available on the company's investor relations website.
Key Highlights
- Acumen Pharmaceuticals will report first quarter financial results on Tuesday, May 12, 2026.
- The company will host a conference call and live audio webcast at 8:00 a.m. ET on May 12, 2026.
- Participants must register in advance for the live conference call.
- An archived version of the webcast will be available for at least 30 days on the company's website.
- Acumen is a clinical-stage biopharmaceutical company focused on Alzheimer's disease therapeutics.
- The company is advancing sabirnetug (ACU193) in its Phase 2 ALTITUDE-AD clinical trial.
Price Impact
More from ABOS